Seeking Alpha

Neuralstem (CUR +7.3%) pops after releasing positive results for its NSI-566 study, a spinal...

Neuralstem (CUR +7.3%) pops after releasing positive results for its NSI-566 study, a spinal cord-derived neural stem cell line tested in a rat model of ischemic stroke. The data showed significant improvement in both motor and neurological tests, with the rats treated with the highest dose showing the most significant improvement in both categories.
Comments (3)
  • nano-nano
    , contributor
    Comments (6) | Send Message
     
    The Aegis analyst update didn't hurt. http://bit.ly/XeUmaM
    15 Oct 2012, 03:48 PM Reply Like
  • Urbane Gorilla!
    , contributor
    Comments (1094) | Send Message
     
    The CEO of $CUR was on twitter the other day 'pimping' his company..Unbelievable.
    15 Oct 2012, 07:17 PM Reply Like
  • nano-nano
    , contributor
    Comments (6) | Send Message
     
    But he has yet to sell a single share....
    16 Oct 2012, 09:35 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs